Antiphospholipid antibodies in patients with persistent Lyme disease symptoms

Abstract

Get full access to this article

View all access options for this article.

References

Greco

Jr Conti-Kelly

Greco

. Antiphospholipid antibodies in patients with purported ‘chronic Lyme disease’. Lupus 2011; 20: 1372–1377.

Miyakis

Lockshin

Atsumi

. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.

Sène

Piette

J-C

Cacoub

. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 2008; 7: 272–277.

Berkun

Zandman-Goddard

Barzilai

. Infectious antibodies in systemic lupus erythematosus patients. Lupus 2009; 18: 1129–1135.

Loizou

Singh

Wypkema

Asherson

. Anticardiolipin, anti-ß2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 2003; 62: 1106–1111.

Galrão

Brites

Atta

. Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol 2007; 26: 1825–1830.

Harada

Fujisawa

Sakisaka

. High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications. J Gastroenterol 2000; 35: 272–277.

Mackworth-Young

Harris

Steere

. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1988; 31: 1052–1056.

García Moncó

Wheeler

Benach

. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides. J Neurol Sci 1993; 117: 206–214.

10.

Stricker

. Counterpoint: long-term antibiotic therapy improves persistent symptoms associated with Lyme disease. Clin Infect Dis 2007; 45: 149–157.

11.

Cameron

. Proof that chronic Lyme disease exists. Interdiscip Perspect Infect Dis 2010; 2010: 876450–876450.

12.

Stricker

Johnson

. Lyme disease: The next decade. Infect Drug Resist 2011; 4: 1–9.